Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001437749-20-012632
Filing Date
2020-06-08
Accepted
2020-06-08 16:48:11
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 dffn20200605_424b3.htm 424B3 249875
2 logo.jpg GRAPHIC 12675
3 zuzxda0iy424b3img001.jpg GRAPHIC 10830
  Complete submission text file 0001437749-20-012632.txt   283782
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-238818 | Film No.: 20949639
SIC: 2834 Pharmaceutical Preparations